GMO Alpha Only IV
40 Rowes Wharf Boston MA 02110
Map
Phone: 800-225-5291
| Category: | World Stock | | Fund Family: | GMO | | Net Assets: | 2.56B | | Year-to-Date Return: | 0.46% | | Yield: | 2.02% | | Morningstar Rating: | N/A | | Fund Inception Date: | 02-Mar-06 |
|
Ben Inker
Lead Manager since
29-Jul-94 | | | Inker is the chief investment officer of quantitative developed equities and director of asset allocation at GMO, which he joined in 1992. Inker holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $125,000,000 | | Min Initial Investment, IRA: | $0 | | Min Initial Investment, AIP: | $0 | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | $0 |
|
| |
| The investment seeks high total return. The fund invests primarily in the underlying funds of GMO U.S. Equity funds and GMO International Equity funds, or directly in equity securities of the type invested by these funds. It may also invest in GMO Emerging Country Debt Fund ("ECDF") or in debt securities of the type invested in by ECDF. The fund will implement the strategy with a combination of US. equities and international equities. It will typically invest in a U.S. equity strategy that will be hedged using exchange traded S&P 500 futures contracts. |
| Last Dividend
(27-Dec-07):
| 0.22 | | Last Cap Gain
| N/A | | Annual Holdings Turnover
| 44.00% | | Average for Category:
| 60.13% |
|
| Expense | GAPOX | Category
Avg | | Total Expense Ratio: | 0.11%
| 1.56% | | Max 12b1 Fee: | 0.00%
| N/A | | Max Front End Sales Load: | 0.00%
| 5.26% | | Max Deferred Sales Load: | 0.00%
| 2.64% | | 3 Yr Expense Projection*: |
$347 | $730 | | 5 Yr Expense Projection*: |
$632 | $1,130 | | 10 Yr Expense Projection*: |
$1,445 | $2,201 |
|
|
0.65% Nasdaq 
0.27%
Profile
